Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide.
Prosus stock has delivered a 32.6% gain over the past 3 years, yet its current checks paint a mixed valuation picture, with market multiples screening the shares as undervalued while the broader score is only middling.
-
A 32.6% return over 3 years suggests Prosus has rewarded patient shareholders, but not to an extent that clearly explains why the market still prices it as undervalued on earnings based measures.
-
Future growth in the value of Prosus' underlying investments can support today's valuation, while any hit to cash flow visibility or balance sheet flexibility may weigh on how much of that value the market is willing to reflect in the share price.
-
With a mixed valuation score of 3 out of 6 checks, Prosus screens as neither a straightforward bargain nor clearly expensive when all metrics are considered together.
The stock's next move may depend on whether that combination of decent long term returns and an undervalued multiple truly adds up to a margin of safety at today's price.
Find out why Prosus' -17.3% return over the last year is lagging behind its peers.
Is Prosus a Bargain on Earnings?
The P/E ratio is a useful starting point for Prosus because earnings are a key reference for many investors when comparing listed holding companies. Right now Prosus trades on a P/E of about 8.4x, which is well below both the multiline retail industry average of roughly 19.9x and the wider peer group average of about 33.1x.
A tailored fair P/E multiple for Prosus, which considers its size, profitability profile and risk factors, sits around 15.9x. That is almost double the current 8.4x, implying the market is putting a relatively low price on each euro of Prosus earnings compared with what this framework suggests might be reasonable. While this does not say how earnings will evolve, it does indicate that, on today's figures, the stock trades at a sizable discount to what the fair ratio model points to.
On the P/E measure alone, Prosus stock appears undervalued relative to both its industry and the fair multiple implied by this model.
See what the numbers say about this price — find out in our valuation breakdown.
The Prosus Narrative: What Would Justify Today's Price?
Simply Wall St Narratives pick up where Prosus' valuation puzzle leaves off, explaining which paths for growth, margins and earnings would need to occur for the stock to be worth materially more or less than it is today. These Narratives are available on the company's Community page. Rather than relying on a single multiple or model output, each one sets out the assumptions behind its view of fair value so you can compare them with Prosus' actual results over time.
One of the top community narratives on Prosus: 36% undervalued
"Prosus has a strong cash position of $10 billion available for investments in opportunities that complement its ecosystem, indicating potential for revenue growth and profitability over time..."
Read one of the top narratives on Prosus
Do you think there's more to the story for Prosus? Head over to our Community to see what others are saying!
The Bottom Line
Prosus screens as undervalued on earnings, with the current P/E sitting well below both industry peers and a tailored fair multiple, but the overall valuation picture is still mixed rather than a clear-cut bargain. The key question is whether the quality and transparency of Prosus' underlying cash flows justify a future re rating, or whether the discount reflects ongoing concerns about the portfolio and capital allocation. For now, the gap between the low multiple and the middling broader checks comes down to one assumption: how much confidence you have that Prosus can convert its investment portfolio into durable, visible earnings over time.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include PRX.AS .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
